课题基金 / 基金详情

PACTG P1021 EMTRICITABINE AND EFAVIRENZ AND DIDANOSINE IN HIV

PACTG P1021 EMTRICITABINE AND EFAVIRENZ AND DIDANOSINE IN HIV
PACTG P1021 恩曲他滨、依非韦伦和地达诺辛治疗 HIV
批准号：
7606519
负责人：
STEPHEN A SPECTOR
金额：
$0.5万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
项目状态：
已结题
起止时间：
2006-12-01 至 2007-11-30
来源：
https://reporter.nih.gov/project-details/7606519
关键词：
Anti-Retroviral AgentsAntiviral AgentsChildhoodComputer Retrieval of Information on Scientific Projects DatabaseDailyDidanosineExposure toFundingGrantInstitutionResearchResearch PersonnelResourcesSafetySourceTreatment ProtocolsUnited States National Institutes of Healthantiretroviral therapyefavirenzemtricitabine

项目摘要

项目成果

STEPHEN A SPECTOR的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Determine the long term safety and tolerance of a regimen of FTC + EFV + ddI administered once daily in HIV-infected pediatric subjects who are naive or have very limited exposure to antiretroviral therapy. Determine the antiviral activity of a regimen of FTC + EFV + ddI administered once daily in treatment of naive or very limited antiretroviral exposed pediatric subjects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU) Administrative Supplement
Modulating Autophagy to Eradicate HIV-1 from CNS Reservoirs
Modulating Autophagy to Eradicate HIV-1 from CNS Reservoirs
Modulating Autophagy to Eradicate HIV-1 from CNS Reservoirs
海外基金